Abstract
AA-PET (MET-PET and FET-PET) can be used for gross tumour volume (GTV) delineation in brain gliomas and for the differentiation between treatment-related changes (pseudo-progression, pseudo-regression) and residual/recurrent tumour. There are some data showing that MET-PET and (DOTATOC)-PET can be used for GTV delineation in meningiomas and glomus tumours. The role of PET in the visualization of the biological characteristics of the tumours: proliferation (FLT-PET), hypoxia (FMISO-PET) and angiogenesis/peptide expression (RGD-PET) should be investigated in future studies.
| Original language | English |
|---|---|
| Pages (from-to) | 325-327 |
| Number of pages | 3 |
| Journal | Radiotherapy and Oncology |
| Volume | 96 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 2010 |
| Externally published | Yes |
Keywords
- Brain tumours
- PET
- Radiation treatment planning
Fingerprint
Dive into the research topics of 'PET for radiation treatment planning of brain tumours'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver